Llovet, Josep M.
Villanueva, Augusto
Lachenmayer, Anja
Finn, Richard S.
Article History
First Online: 9 June 2015
Change Date: 23 June 2015
Change Type: Correction
Change Details: In the version of the article published in print, the legends for Figures 3 and 4 were published in the incorrect order. These errors have been corrected for the HTML and PDF versions of the article published online.
Competing interests
: J.M.L. has served as an advisory board member for Bayer Pharmaceuticals, Boehringer Ingelheim and Bristol Myers Squibb and an advisor for Biocompatibles, Blueprint, Celgene, Celsion, GlaxoSmithKline, Lilly Pharmaceuticals and Novartis. A.V. and R.S.F. declare they have acted as advisors for Bayer Pharmaceuticals and Onyx Pharmaceuticals, R.S.F. has also acted as an advisor for Bristol Myers Squibb, Novartis and Pfizer. A.L. declares no competing interests.
Free to read: This content has been made available to all.